Install
Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth anal
- 2,780articles · 30d
- 2+ hour agolatest article
- Aug 15, 2026earliest in window
- 95%with images
- 65avg words
- Economy, Business & Finance 2,411
- Finance & Business 2,280
- News 1,153
- Finance 875
- Business & Industrial 421
- Industrial 124
- Science & Technology 117
- Politics 93
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Anthropic CEO calls for pacing AI development, setting guardrails (ANTHRO:Private)
2+ hour, 46+ min ago (53+ words) Seeking Alpha Anthropic CEO Dario Amodei said on X that AI companies should slow down their advancement efforts amid fears of misuse. In his post, Amodei set out a three-step plan to pace development while managing risks. "We must slow…...
Elon Musk ‘confident’ of launching Nvidia AI platforms in space in 2027 (NVDA:NASDAQ)
2+ hour, 27+ min ago (56+ words) Seeking Alpha Elon Musk said in a reply to a post on X that he is confident that SpaceX (SPCX) will launch Nvidia (NVDA) AI computers in space in 2027. Nvidia’s Vera Rubin NVL72 is an AI computer platform with leading-edge technologies...
???Practical Magic 2??? tanks with $30M opening as domestic box office slows (AMC:NYSE)
13+ hour, 57+ min ago (95+ words) ‘Practical Magic 2’ tanks with $30M opening as domestic box office slows (AMC:NYSE) Seeking Alpha Practical Magic 2 didn't cast much of a spell over moviegoers this weekend, opening at No. 1 with an estimated $30 million in domestic ticket sales, according to Rentrak....
Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial (SMMT:NASDAQ)
14+ hour, 27+ min ago (64+ words) Seeking Alpha nopparit/iStock via Getty Images Summit Therapeutics (SMMT) on Sunday said ivonescimab significantly extended survival compared with Merck’s (MRK) Keytruda in a late-stage lung cancer trial conducted by its partner Akeso (AKESF) in China. Ivonescimab reduced the risk…...
Anthropic is said to pick Nasdaq for potential IPO (ANTHRO:Private)
14+ hour, 57+ min ago (52+ words) Seeking Alpha Artificial intelligence startup Anthropic (ANTHRO) selected Nasdaq as the exchange for a possible initial public offering, Business Insider reported Sunday, citing a person familiar with the company’s plans. The decision would move Anthropic (ANTHRO) another step toward becoming…...
Trump rejects calls for AI slowdown, citing race with China (ANTHRO:Private)
15+ hour, 5+ min ago (85+ words) Seeking Alpha President Donald Trump dismissed mounting warnings about artificial intelligence, arguing that slowing development could jeopardize the United States’ lead over China, Bloomberg News reported. “We’re leading China in AI. We’re the most sophisticated country in the world, and…...
Goldman Sachs sees rate shock, not bull-market killer, for U.S. stocks
16+ hour, 49+ min ago (13+ words) Seeking Alpha...
Johnson urges caution on AI legislation as tech chiefs call for safeguards (ANTHRO:Private)
18+ hour, 23+ min ago (87+ words) Seeking Alpha House Speaker Mike Johnson said Congress should consult the leaders of the nation’s largest artificial-intelligence companies before moving ahead with broad federal regulations, arguing that lawmakers cannot afford to rush legislation governing the rapidly advancing technology. Johnson told…...
Rent the Runway: Profit Is Maturing, But Subscriber Declines Remain Concerning
20+ hour, 18+ min ago (58+ words) (Rating Upgrade) Seeking Alpha - Rent the Runway has suffered a ~70% share price decline in 2026 despite maintaining >20% y/y revenue growth and positive adjusted EBITDA. - I now rate RENT as neutral, seeing a more balanced risk/reward profile at current depressed…...
Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification
21+ hour, 40+ min ago (89+ words) Seeking Alpha - Kardigan targets genetic DCM, moderate CAVS, and post-hospitalization ASH with differentiated, biology-driven clinical programs. - KARD holds $660.7M in liquid assets, providing roughly 2–3 years of runway to achieve key clinical readouts before further funding is needed. - Upcoming 2027 data from all…...